Drug recall · March 7, 2018
Levofloxacin in 5% Dextrose Injection recall
Why: Presence of Particulate Matter; contains visible particulate matter identified as mold.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, Manufactured for: AuroMedics Pharma LLC 6 Wheeling Drive, Dayton, NJ 08810 Manufactured for: Aurobindo Pharma Limited IDA, Pashamylaram - 502307, India ---- NDC 55150-243-46
- Lots / codes
Lot CLF160003, exp May 2018
- Quantity
- 6,072 bags
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide
- Initiated
- January 12, 2018 · Voluntary: Firm initiated
- Classified
- March 1, 2018
- Reported
- March 7, 2018
- Ended
- April 1, 2020
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levofloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.